2026 PROFESSIONAL PSYCHIATRY COURSE

Comprehensive Review of Psychiatry 2026

Name: Oakstone Comprehensive Review of Psychiatry 2026
SKU: 6318
Availability: InStock

Psychiatry Video Course | DSM-5 Diagnosis, Psychopharmacology, Psychotherapy & Evidence-Based Mental Health Care

🎥 More Than 50 Expert-Led Lectures

📄 Presentation Handouts (PDF)

📅 July 31, 2026

The Comprehensive Review of Psychiatry 2026 is a comprehensive educational
program designed to provide psychiatrists and psychiatry residents with a practical,
evidence-based review of modern clinical psychiatry. Featuring more than 50 expert-led
lectures, this course covers the complete spectrum of psychiatric disorders, diagnosis,
treatment strategies, psychopharmacology, psychotherapy, and emerging innovations shaping
mental health practice.

Developed by internationally recognized psychiatry experts, this course combines current
clinical guidelines, DSM-5 diagnostic principles, practical treatment recommendations, and
real-world case discussions to help clinicians confidently diagnose and manage patients
across inpatient, outpatient, consultation-liaison, and community psychiatry settings.

Participants will gain up-to-date knowledge in mood disorders, schizophrenia, anxiety
disorders, obsessive-compulsive disorder (OCD), trauma-related disorders, ADHD,
neurocognitive disorders, personality disorders, substance use disorders, psychiatric
emergencies, psychopharmacology, cognitive behavioral therapy, treatment-resistant depression,
artificial intelligence in psychiatry, psychedelic therapies, medicinal cannabis,
telepsychiatry, and much more.

Release Date: July 31, 2026

✦ Course Package Includes

🎥 Complete Video Course

📄 Presentation Handouts (PDF)

✦ Who Should Attend?

This course is ideal for:

🩺 Psychiatrists

🎓 Psychiatry Residents

✦ Learning Objectives

After completing this course, participants will be able to:

✓ Perform comprehensive psychiatric assessment, screening, and diagnosis.

✓ Differentiate psychiatric disorders using DSM-5 diagnostic criteria.

✓ Apply evidence-based pharmacologic and psychotherapeutic treatment strategies.

✓ Compare currently available mood stabilizers and their clinical applications.

✓ Recognize schizophrenia, psychosis, personality disorders, trauma-related disorders,
dissociative disorders, and neurocognitive disorders.

✓ Manage treatment-resistant depression and complex psychiatric disorders.

✓ Apply current recommendations for psychopharmacology and psychotherapy.

✓ Integrate psychiatric and medical care.

✓ Utilize modern treatment approaches including psychedelic therapies, medicinal cannabis,
telepsychiatry, GLP-1 receptor agonists, and Artificial Intelligence in Psychiatry.

✓ Address legal, ethical, competency, and capacity issues encountered in psychiatric practice.

📚 Topics

Comprehensive coverage of modern clinical psychiatry

Approach to the Patient

Screening, Evaluation, and Diagnosis —
Antoine Douaihy, MD

Psychiatric Disorders

Schizophrenia and Other Psychotic Disorders — Sanya Virani, MD, MPH, FAPA

Depressive and Bipolar Disorders in Adults — Madeleine R. Lepore, DNP

Bipolar and Related Disorders in Youth — Rasim Somer Diler, MD, DFAACAP

Anxiety Disorders — Thersilla Oberbarnscheidt, MD, PhD

Obsessive Compulsive and Related Disorders — Robert Hudak, MD

Trauma and Stressor-Related Disorders — Brigitte Khoury, PhD

Personality Disorders — Vint Blackburn, MD

Dissociative Disorders — Pamela R. Fuller, PhD

Major Neurocognitive Disorders — Rita Khoury, MD

Psychiatric Emergencies — Varad Deshmukh, MD

Feeding and Eating Disorders — Tala Abdallah, DClinPsy

Somatic Symptoms and Related Disorders — Soumitra Das, MD

Sleep Medicine for the Psychiatrist — Shizuka Tomatsu, MD

Suicide Epidemiology and Risk Assessment — Nadine Melhem, PhD

Substance-Related Disorders — Antoine Douaihy, MD

Violence and Psychiatry — Stephanie Rolin, MD

Gambling Disorder — Kavita Fischer, MD

Reproductive Psychiatry — Jody Glance, MD

Psychiatric Manifestations of Common Medical Conditions — Daniel Salahuddin, MD

Psychiatric Aspects of HIV and HCV — Jordi Blanch, MD

Chronic Pain for the Psychiatrist: A Clinical Update — Xavier Jimenez, MD

Intellectual Disabilities — Antonio Hardan, MD

Attention Deficit Hyperactivity Disorder Across the Lifespan: Children, Adolescents, and Adults — Fadi Maalouf, MD, PhD

Anxiety and Mood Disorders in Children and Adolescents — Fadi Maalouf, MD, PhD

Psychiatric Issues in the LGBTQIA+ Population: Cultivating Resilience, Health, and Emotional Wellbeing — Antoine Douaihy, MD

Psychiatric Genetics — Ilya Blokhin, MD, PhD

Treatments: Psychopharmacology

Antidepressants and Mood Stabilizers — Megha Patel, PharmD, BCPS

Antipsychotics: A Case-Based Approach — K.N. Roy Chengappa, MD

Anxiolytics and Sedative-Hypnotic Agents — Tanya Fabian, PharmD, PhD

Psychopharmacological Treatments of Substance Use Disorders (SUDs) — Antoine Douaihy, MD

Pharmacological Treatments of Attention Deficit Hyperactivity Disorder — Rebecca Miller, MD

Treatment of Major Neurocognitive Disorders — Rita Khoury, MD

Treatments: Psychotherapy

Cognitive Behavioral Therapy (CBT) — Jennifer E. Wildes, PhD

Dialectical Behavior Therapy (DBT) — Stephanie Stepp, PhD

Social Rhythm Therapy — Holly Swartz, MD

Motivational Interviewing — Antoine Douaihy, MD

Couples and Family Therapy — Jay Lebow, PhD

Positive Psychiatry — Dennis C. Daley, PhD

Other Treatments

Management of Treatment-Resistant Depression — Matt Conlon, MD

Update on Electroconvulsive Therapy (ECT) — LalithKumar Solai, MD

Psychedelic Compounds in Psychiatry: Novel Treatment Paradigms in Mental Health — Danilo De Gregorio, PharmD, PhD

Medicinal Cannabis — Antoine Douaihy, MD

Special Topics

Integrating Medical and Psychiatric Care — Alex Israel, MD

Telepsychiatry: Potential and Challenges — Robert Tessier, MD

Palliative Care Psychiatry — Elizabeth Hale, MD

Climate Change and Mental Health — Antoine Douaihy, MD

GLP-1 Receptor Agonists and Psychiatric Illness — Antoine Douaihy, MD

Artificial Intelligence and Psychiatry — Shiri Sadeh-Sharvit, MD

The Impact of Social Media Use on Mental Health — Candice Biernesser, MD

Mindfulness-Based Interventions and Psychiatric Disorders — Antoine Douaihy, MD

Legal and Ethical Issues in the Practice of Psychiatry — Sanya Virani, MD, MPH, FAPA

Competency and Capacity in Clinical Practice — Elias Ghossoub, MD

✦ Why This Course?

Modern psychiatry continues to evolve with new diagnostic frameworks, pharmacologic therapies,
psychotherapeutic approaches, and technological innovations.
Comprehensive Review of Psychiatry 2026 delivers an evidence-based review
of the disorders and treatments encountered in everyday psychiatric practice while exploring
emerging areas such as Artificial Intelligence, psychedelic-assisted therapies,
GLP-1 receptor agonists, telepsychiatry, medicinal cannabis, and integrated behavioral healthcare.

With over 50 expert-led lectures, this course is an outstanding resource
for psychiatrists and psychiatry residents preparing for board examinations, refreshing
core concepts, or staying current with advances in psychiatric diagnosis and treatment.

🎥 50+ EXPERT-LED LECTURES

📄 PDF HANDOUTS

🧠 DSM-5 DIAGNOSIS

💊 PSYCHOPHARMACOLOGY

🧩 PSYCHOTHERAPY

📅 JULY 31, 2026

Reviews

There are no reviews yet.

Be the first to review “Oakstone Comprehensive Review of Psychiatry 2026”

Oakstone Comprehensive Review of Psychiatry 2026

Comprehensive Review of Psychiatry 2026

✦ Course Package Includes

✦ Who Should Attend?

✦ Learning Objectives

📚 Topics

✦ Why This Course?

Reviews

Quick links

Frequently bought with Oakstone Comprehensive Review of Psychiatry 2026

Oakstone Comprehensive Review of Psychiatry 2026

Comprehensive Review of Psychiatry 2026

✦ Course Package Includes

✦ Who Should Attend?

✦ Learning Objectives

📚 Topics

✦ Why This Course?

Reviews

Related products

Johns Hopkins Perioperative Management-In Its 41st Year 2026

Scripps Structural Heart Intervention and Imaging 2026

Surgicall Academy 10th All in One Rhinoplasty Congress 2025

Quick links

Frequently bought with Oakstone Comprehensive Review of Psychiatry 2026